Semo, D., Reinecke, H., & Godfrey, R. (2024). Gut microbiome regulates inflammation and insulin resistance: A novel therapeutic target to improve insulin sensitivity. Signal transduction and targeted therapy, 9(1), 35-3. https://doi.org/10.1038/s41392-024-01746-y
Chicago Style (17th ed.) CitationSemo, Dilvin, Holger Reinecke, and Rinesh Godfrey. "Gut Microbiome Regulates Inflammation and Insulin Resistance: A Novel Therapeutic Target to Improve Insulin Sensitivity." Signal Transduction and Targeted Therapy 9, no. 1 (2024): 35-3. https://doi.org/10.1038/s41392-024-01746-y.
MLA (9th ed.) CitationSemo, Dilvin, et al. "Gut Microbiome Regulates Inflammation and Insulin Resistance: A Novel Therapeutic Target to Improve Insulin Sensitivity." Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, pp. 35-3, https://doi.org/10.1038/s41392-024-01746-y.